North America Liquid Biopsy Market - Global Drivers, Opportunities, Trends, and Forecasts to 2027

 


Market Introduction

Liquid biopsy is a revolutionary technology that is opening up various perspectives. The technology consists of isolation and detection of circulating tumor cells, circulating tumor DNA and exosomes, which provides genomic information of the cancer patients. Liquid biopsy are used in cancer diagnosis in order to study response or resistance to given treatments.

Moreover, in the United States, due to an increasing number of infected patients, healthcare professionals and leading organizations are distracting the flow of healthcare resources from research & development to primary care, which is slowing down the process of innovation. Furthermore, the pandemic spread is also preventing the clinical trials, drug development, and diagnostic industry in the US. For instance, California-based Lucence Diagnostics Pte Ltd., who develops liquid biopsy and has a known player in this industry, has been diverted now to manufacture kits for COVID-19.

📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲@ https://www.businessmarketinsights.com/sample/TIPRE00013010

The North America Liquid Biopsy Market is witnessing significant growth due to the increasing demand for non-invasive cancer diagnostic techniques. Liquid biopsy, a revolutionary method that involves the sampling and analysis of non-solid biological tissue, primarily blood, offers a less invasive and quicker alternative to traditional tissue biopsies. This method is especially valuable in oncology for detecting cancer-related biomarkers, monitoring disease progression, and assessing treatment response. As healthcare systems across the region shift toward precision medicine and personalized therapies, the North America Liquid Biopsy Market continues to expand its footprint across clinical settings.

One of the primary drivers of the North America Liquid Biopsy Market is the rising prevalence of cancer in the region. Early detection plays a crucial role in improving survival rates, and liquid biopsy provides an effective solution for identifying cancers at an early stage. The procedure's ability to detect minimal residual disease, track tumor evolution, and offer real-time insights into the genetic profile of tumors makes it indispensable in modern oncology practices. Furthermore, its application is not limited to cancer detection alone. It is also being utilized in monitoring organ transplant rejection, prenatal testing, and detecting other chronic diseases, thereby broadening the market scope.

The increasing adoption of advanced molecular diagnostic technologies has also boosted the North America Liquid Biopsy Market. Innovations in next-generation sequencing, digital PCR, and other analytical tools have improved the sensitivity and accuracy of liquid biopsy tests. These advancements enable clinicians to make informed decisions quickly, enhancing patient care and outcomes. As research in genomics and molecular biology deepens, the integration of these technologies with liquid biopsy procedures will further drive the growth of the North America Liquid Biopsy Market.

📚𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐋𝐢𝐧𝐤 @ https://www.businessmarketinsights.com/reports/north-america-liquid-biopsy-market

Moreover, the aging population and lifestyle-related risk factors such as smoking, alcohol consumption, and unhealthy diets are contributing to the rising cancer incidence, further pushing the demand in the North America Liquid Biopsy Market. The preference for non-invasive diagnostic solutions among older patients, who may not be ideal candidates for surgical procedures, underscores the value proposition of liquid biopsy in this demographic. Additionally, growing awareness and health consciousness among the general population have led to increased screening and diagnostic testing, supporting the expansion of the North America Liquid Biopsy Market.

Another key trend influencing the North America Liquid Biopsy Market is the shift toward outpatient and decentralized testing models. With the growth of home-based and point-of-care diagnostics, liquid biopsy is becoming more accessible to patients outside traditional healthcare facilities. This transition not only improves convenience and reduces the burden on healthcare infrastructure but also promotes early diagnosis and continuous monitoring. As telehealth and remote diagnostics gain traction, the role of liquid biopsy in the North America Liquid Biopsy Market is expected to grow stronger. In summary, the North America Liquid Biopsy Market is undergoing rapid transformation driven by technological advancements, growing cancer burden, and the increasing focus on early diagnosis and precision medicine. As the healthcare ecosystem evolves, the importance of non-invasive, accurate, and real-time diagnostic tools like liquid biopsy will only increase, cementing its role in the future of medical diagnostics across North America.

Market Overview and Dynamics

The North America liquid biopsy market is expected to reach US$ 3,531.44 Mn in 2027 from US$ 1,522.58 Mn in 2018. The market is anticipated to grow with a CAGR of 10.1% from 2019-2027. Factors driving the market growth include increasing prevalence of cancer. However, low sensitivity of liquid biopsy is likely to have a negative impact on market growth.

Key Market Segments

By product & services, the reagents and kits segment accounted for the largest market share in the North American liquid biopsy market in 2018. In terms of sample, the blood based segment held the largest market share of the liquid biopsy market by 2027. By circulating biomarker, the circulating tumor cells (CTC) segment accounted for the largest market share in the North American liquid biopsy market in 2019. By 2027, the oncology segment accounted for the largest market share by application. Furthermore, in terms of end user, the reference laboratories segment held the largest market share of the liquid biopsy market by 2027.

𝐓𝐡𝐞 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

Thermo Fisher Scientific Inc.

Bio-Rad Laboratories Inc.

Exact Sciences Corporation

Biocept, Inc

Inivata Ltd

North America Liquid Biopsy Regional Insights

The geographic scope of the North America Liquid Biopsy refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

You can see this-

North America Railway Cyber Security Market- https://businessmarketresportsnews.blogspot.com/2025/05/north-america-railway-cyber-security.html

North America Outdoor Power Equipment Market- https://sites.google.com/u/0/d/1s4wgpF1pLQ62FNewoaD0K3NsDI1a8aiv/p/1X-kxEQgONWeb3rmWeb8xW_LyG-7tZmxq/publishview

North America Smart Inhalers Market- https://postyourarticle.com/north-america-smart-inhalers-market-key-players-size-trends-opportunities-growth-analysis-to-2027-2/


Comments

Post a Comment

Popular posts from this blog

Europe Electric Ship Market Key Players, Growth, Trends, Share, Opportunities, Forecast 2028

Image
  The Europe electric ship market is expected to grow from US$ 1867.68 million in 2021 to US$ 3273.91 million by 2028; it is estimated to grow at a CAGR of 8.3% from 2021 to 2028. The Europe Electric Ship Market is experiencing significant growth due to increasing environmental awareness, advancements in maritime technologies, and the urgent need to reduce emissions from the shipping industry. This market is driven by the demand for eco-friendly solutions in the maritime sector, and electric ships offer a promising alternative to traditional fossil-fuel-powered vessels. With stricter environmental regulations being implemented across Europe, the Europe Electric Ship Market is expected to expand rapidly in the coming years. Electric ships are designed to operate on electric power, utilizing batteries or other renewable energy sources instead of conventional marine fuels like diesel or heavy fuel oil. These vessels are not only more environmentally friendly but also help reduce ope...
Read more

Europe Electric Ship Market Key Players, Growth, Trends, Share, Opportunities, Forecast 2028

Image
  The Europe electric ship market is expected to grow from US$ 1867.68 million in 2021 to US$ 3273.91 million by 2028; it is estimated to grow at a CAGR of 8.3% from 2021 to 2028. Several marine industry associations are focusing on reducing the gas emission from the shipping industry. For instance, according to a report published by the Norwegian Ministry of Climate and Environment, in April 2018, the International Maritime Organization (IMO) adopted a plan to reduce greenhouse gas emissions from international shipping by at least 50% by the end of 2050 compared with the level in 2008. Additionally, the IMO strategy includes ambitions to improve the energy efficiency of each ship and to reduce the carbon intensity of the whole marine industry by reducing emissions per unit of transport work done by at least 40% by 2030 and further towards 70% by 2050, according to report published by the Norwegian Ministry of Climate and Environment. Also, in January 2020, according to IMO 2020 ...
Read more

Europe Electric Ship Market Key Details and Outlook by Top Companies till 2028

Image
  The Europe electric ship market is expected to grow from US$ 1867.68 million in 2021 to US$ 3273.91 million by 2028; it is estimated to grow at a CAGR of 8.3% from 2021 to 2028. The Europe Electric Ship Market is experiencing robust growth due to the increasing focus on reducing carbon emissions in the maritime industry. The push towards sustainable transportation has significantly accelerated the adoption of electric propulsion technologies in ships across Europe. Governments and maritime authorities are implementing strict emission regulations, further propelling the demand for electric ships in the region. As a result, the Europe Electric Ship Market is emerging as a key component in achieving Europe’s green transportation objectives. The Europe Electric Ship Market is primarily driven by the rising need for cleaner and more efficient marine transport solutions. Traditional ships powered by fossil fuels contribute significantly to greenhouse gas emissions and marine pollut...
Read more